A novel Affibody bioconjugate for dual-modality imaging of ovarian cancer

2014 ◽  
Vol 50 (85) ◽  
pp. 12832-12835 ◽  
Author(s):  
Yihong Wang ◽  
Zheng Miao ◽  
Gang Ren ◽  
Yingding Xu ◽  
Zhen Cheng

An Affibody based dual imaging probe (PET and optical imaging) has been successfully developed. Dendrimer PAMAM G0 was used as a platform to assemble an NIRF dye, a metal chelator, and Affibody for dual modality imaging of ovarian cancer. Excellent tumor imaging quality was achieved in both modalities in the living tumor mice models.

2015 ◽  
Vol 3 (9) ◽  
pp. 1788-1800 ◽  
Author(s):  
Mathieu Bédard ◽  
Pramod K. Avti ◽  
Tina Lam ◽  
Léonie Rouleau ◽  
Jean-Claude Tardif ◽  
...  

Hollow gold nanoshells functionalized with branched multivalent ligands provide an excellent platform to develop nanoprobes with dual imaging capabilities.


2016 ◽  
Vol 4 (35) ◽  
pp. 5798-5802 ◽  
Author(s):  
Cuiping Han ◽  
Huiting Xu ◽  
Ru Wang ◽  
Keying Wang ◽  
Yue Dai ◽  
...  

A magnetic-fluorescent manganese(ii)–carbon dots hybrid nanoprobe was successfully prepared for ovarian cancer cell targeting and bifunctional MRI and optical imaging.


2018 ◽  
Vol 2 (4) ◽  
pp. 306-319 ◽  
Author(s):  
Kai Li ◽  
Carmel T. Chan ◽  
Hossein Nejadnik ◽  
Olga D. Lenkov ◽  
Cody Wolterman ◽  
...  

2017 ◽  
Vol 14 (10) ◽  
pp. 3457-3463 ◽  
Author(s):  
Marlène C. H. Hekman ◽  
Otto C. Boerman ◽  
Desirée L. Bos ◽  
Leon F. A. G. Massuger ◽  
Susan Weil ◽  
...  

2016 ◽  
Vol 23 (9) ◽  
Author(s):  
Shan Xia ◽  
Hongyu Yang ◽  
Lijie Duan ◽  
Guang Hui Gao ◽  
Xiumei Zhang

2020 ◽  
Vol 11 (5) ◽  
pp. 1010-1017 ◽  
Author(s):  
Yuhuan Li ◽  
Fangyun Xin ◽  
Jinming Hu ◽  
Shweta Jagdale ◽  
Thomas P. Davis ◽  
...  

A thrombosis-targeted molecular imaging probe with magnetic resonance (MR) and optical dual-modality capacity using dibromomaleimide (DBM)-bearing polymer-grafted NaGdF4 nanoparticles.


2014 ◽  
Vol 43 (2) ◽  
pp. 439-450 ◽  
Author(s):  
Alison François ◽  
Céline Auzanneau ◽  
Valérie Le Morvan ◽  
Chantal Galaup ◽  
Hannah S. Godfrey ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Zhu Fei-Peng ◽  
Chen Guo-Tao ◽  
Wang Shou-Ju ◽  
Liu Ying ◽  
Tang Yu-Xia ◽  
...  

Dual-modal imaging by combining magnetic resonance (MR) and near-infrared (NIR) fluorescence can integrate the advantages of high-resolution anatomical imaging with high sensitivity in vivo fluorescent imaging, which is expected to play a significant role in biomedical researches. Here we report a dual-modality imaging probe (NIR/MR-MSNs) fabricated by conjugating NIR fluorescent heptamethine dyes (IR-808) and MR contrast agents (Gd-DTPA) within highly aminated mesoporous silica nanoparticles (MSNs-NH2). The dual-modality imaging probes NIR/MR-MSNs possess a size of ca. 120 nm. The NIR/MR-MSNs show not only near-infrared fluorescence imaging property with an emission peak at 794 nm, but also highly MRT1relaxivity of 14.54 mM−1 s−1, which is three times more than Gd-DTPA. In vitro experiment reveals high uptake and retention abilities of the nanoprobes, while cell viability assay demonstrates excellent cytocompatibility of the dual-modality imaging probe. After intratumor injection with the NIR/MR-MSNs, MR imaging shows clear anatomical border of the enhanced tumor region while NIR fluorescence exhibits high sensitive tumor detection ability. These intriguing features suggest that this newly developed dual-modality imaging probes have great potential in biomedical imaging.


Sign in / Sign up

Export Citation Format

Share Document